Study With Two Different Doses of Desmopressin Orally Lyophilisate Tablet With Nocturnal Enuresis
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
This is multi-center, randomized, placebo-controlled, parallel-group, double-blind,
dose-escalating clinical trial designed to assess the efficacy and safety of desmopressin
orally lyophilisate for the treatment of nocturnal enuresis "with decreased nighttime urinary
osmolality."